Mixed Phenotype Acute Leukemia — Trials

Mixed Phenotype Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

96 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 29
Ph III recruiting: 2
Growth YoY: —
Industry share: 17%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: 41.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–29 of 29 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03802695	A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	recruiting	Phase 1	300	Orca Biosystems, Inc.INDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT04375631	CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia	recruiting	Phase 1	120	Fred Hutchinson Cancer CenterOTHER	1	Sep 17, 2026